On 04/23/2021 FDA clears Truebinding IND application for TB006 in treatment of Alzheimer's patients!
On 04/23/2021 FDA Grants Clearance of IND Application to TB006 for the Treatment of Alzheimer’s Disease
On 03/09/2021 FDA Clears IND Application for TB006 for COVID-19 patients
AT A GLANCE
TrueBinding Inc. is a clinical stage biotherapeutic company focusing on creating new and exciting molecules for applications in immuno-oncology and other disease areas with great unmet medical need including neurological disorders and neurodegenerative diseases.
Based on the application of the Truebinding™ platform, TrueBinding has to date discovered over 6 novel ligands, previously uncharacterized, to receptors of known checkpoint inhibitor pathways.
Our proprietary TrueBindingTM technology is proven to be a powerful tool to discover new targets and their binding partners. Our technology is superior to other traditional approaches. The novel interactions identified by TrueBindingTM technology are confirmed in various in vitro and in vivo assays. TrueBinding, Inc has over sixteen patent applications in its portfolio protecting discoveries and their utility.
TrueBinding, Inc has a number of programs in its portfolio at different stages of development.
Dr. Dongxu Sun
Co-founder & CEO
Lead discovery efforts at ImmuNext
Successfully identified new protein binding interactions in cytokine signaling pathways
Project Scientist at Cleveland Clinic
Postdoctoral training at Cornell Medical College
Dr. Fan Chen
SVP of CMC and GMP
20+ years of experience in Bioprocess Development
VP of Process Development at LakePharma
Senior Leader of Process Development at Dendreon and MedImmune
MD. Thomas Wisniewski
Director of Alzheimer’s Disease Center
NYU School of Medicine
Dr. Charles Glabe
Distinguished professor at UCI and a pioneer in Amyloid pathogenesis.
Fellows of National Academy of Inventors and AAAS
PhD. MD. Adam Boxer
Director of Neurosciences
Clinical Research at UCSF
MD. Mitchel Berger
Chair of neurological surgery department at UCSF
Director of the Brain Tumor Research Center
President, American Association of Neurological Surgeons
President, American Academy of Neurological Surgery
Professor Debbie Thurmond
Key opinion leader in the field of Diabetes and Metabolism.
Founding Chair of the Department of Molecular & Cellular Endocrinology at the City of Hope Beckman Research Institute
Deputy Director of the Diabetes & Metabolism Research Institute
For any inquiries, questions or commendations, please fill out the following form